These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 31877303)
21. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
22. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades. Zhao G; Yin Y; Zhao B J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway. Bi CL; Zhang YQ; Li B; Guo M; Fu YL J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929 [TBL] [Abstract][Full Text] [Related]
24. CircLDLR Promotes Papillary Thyroid Carcinoma Tumorigenicity by Regulating miR-637/LMO4 Axis. Jiang YM; Liu W; Jiang L; Chang H Dis Markers; 2021; 2021():3977189. PubMed ID: 34925640 [TBL] [Abstract][Full Text] [Related]
25. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway. Du Y; Zhu J; Chu BF; Yang YP; Zhang SL Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898 [TBL] [Abstract][Full Text] [Related]
26. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma. Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410 [TBL] [Abstract][Full Text] [Related]
27. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
29. MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation. Chen G; Gao Y; Wang G; Dai G; Tong L J Cell Biochem; 2020 Jun; 121(5-6):3325-3332. PubMed ID: 31907977 [TBL] [Abstract][Full Text] [Related]
30. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
31. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1. Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis. Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756 [TBL] [Abstract][Full Text] [Related]
33. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
34. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818 [TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway. Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358 [TBL] [Abstract][Full Text] [Related]
36. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Sun Z; Zhang M; Ye Y; Yang L Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
38. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
39. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis. Li G; Kong Q Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440 [TBL] [Abstract][Full Text] [Related]
40. miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11. Song M; Wang N; Li Z; Zhang Y; Zheng Y; Yi P; Chen J J Cell Biochem; 2020 Feb; 121(2):984-995. PubMed ID: 31489990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]